MAPT and Cognitive impairment: Alterations in cerebrospinal fluid (CSF) and plasma Aβ42 levels slightly precede changes in total and phospho-tau (pTau) levels, while neuropathological burden of tau pathology correlates better with the severity of cognitive impairment compared to Aβ pathology [28, 50, 71].